Full-service clinical development for cardiovascular and metabolic diseases.

Depth of cardiovascular & metabolic experience

Our project teams are dedicated exclusively to supporting cardiovascular and metabolic studies and have a specialized focus on clinical development for cardiovascular-kidney-metabolic syndromes and comorbidities.

Patient-focused clinical development

Your patients are important to us. We work to ensure your trial is designed for the needs of patients and their families to reduce the burden of participation for better recruitment and retention.

Complex program expertise

Partner with an experienced cardiovascular and metabolic CRO to ease the challenges of your program. Our operational and strategic teams are well-versed in the execution of complex programs, logistics, and data management.

0 +
0 +
0 +
Icon list

We specialize in cardiovascular-kidney-metabolic syndromes, including MASH/MASLD, obesity, type 1 diabetes, congestive heart failure, pulmonary arterial hypertension, lipid disorders, and other liver diseases across all phases of development. Our multidisciplinary team includes extensive clinical and development expertise, so you can trust our solutions have integrated medical, scientific, operational, and strategic considerations.

Icon list

Successful global studies start with an experienced regulatory team. Our teams at Worldwide are highly proficient in global and local regulatory considerations and have established relationships with agencies around the world to support agency engagement.

Icon list

We’re connected with the resources needed to drive successful cardiovascular and metabolic trials forward. We’ve built relationships with leading KOLs and sites and have access to the imaging and specialty vendors and labs required to execute these trials. We also have an in-house bioanalytical lab ready to support your trial.

Icon list

The patient voice plays a vital role in our trial design, easing patient burden and promoting successful recruitment and retention. Our plans encourage diversity and are culturally and linguistically sensitive for better trial outcomes. We also prioritize site education and resources to reduce medical bias and improve understanding of the disease process.

Worldwide Clinical Trials is focused on design and appropriate execution and reporting of clinical trial data. The mission is pretty clear…When you deal with big CROs, if we make a change in a process because we think that’s the right thing to do, it’s not enough for them just to do it because we want it. They’re less concerned about that at Worldwide…they’re more concerned about doing the right thing.

Small Biopharmaceutical Customer Director of Clinical Operations

It was an open, honest, but enthusiastic work environment that [Worldwide Clinical Trials] really provided. They paid attention to us as a small company…and they made us feel like one of their more important clients, even if we weren’t, and that was all the difference.

Senior Vice President of Program Operations Small Biopharmaceutical Customer

We really appreciate the strong collaborative partnership we’ve developed with Worldwide which is based on shared accountability. I see us awarding them more studies in the future.

Sr. Vice President of Clinical Development and CMS Clinical Stage Biotech Company

Awards

On May 1st, Industry Standard Research (ISR) announced the 2024 Leadership Awards, recognizing Phase 2/3 CROs for comprehensive excellence across their capabilities, compatibility, expertise, quality, and reliability.

In 2023, Worldwide Clinical Trials was named Most Innovative Clinical Research Organization (CRO) by the Triangle Business Journal (TBJ). This awards program celebrates the achievements of individuals and companies making critical advancements in pharmaceuticals, biotech, ag tech, and beyond, in the Triangle region of North Carolina.

Worldwide Clinical Trials, Inc., (Worldwide) the industry’s leading global, midsize, full-service contract research organization (CRO), has been recognized for excellence and honored in five categories in the 2022 CRO Leadership Awards, based on primary market research from Industry Standard Research (ISR) Reports and presented by Clinical Leader and Life Science Leader magazines. This marks the ninth consecutive year that Worldwide has been recognized as a high-performing CRO based on direct survey feedback from pharmaceutical and biotech professionals.

Over 80% of respondents agreed that midsize CROs provide a strong cultural fit while being able to pivot quickly based on changing customer needs.